Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 114,493 | 139,163 | 134,224 | 121,984 | 114,802 |
| Cost of Goods | 33,743 | 50,348 | 58,598 | 54,757 | 53,705 |
| Gross Profit | 80,750 | 88,815 | 75,626 | 67,227 | 61,097 |
| Operating Expenses | 23,219 | 26,411 | 25,212 | 25,186 | 26,921 |
| Operating Income | 58,274 | 62,752 | 51,012 | 42,798 | 34,881 |
| Interest Expense | 2,100 | 1,626 | 1,675 | 1,834 | 1,975 |
| Other Income | 953 | 468 | -1,822 | -867 | 544 |
| Pre-tax Income | 57,127 | 61,594 | 47,515 | 40,097 | 33,450 |
| Income Tax | 11,799 | 12,215 | 11,087 | 5,878 | 6,546 |
| Net Income Continuous | 45,328 | 49,379 | 36,428 | 34,219 | 26,904 |
| Net Income | $45,328 | $49,379 | $36,428 | $34,219 | $26,904 |
| EPS Basic Total Ops | 0.19 | 0.22 | 0.15 | 0.14 | 0.11 |
| EPS Basic Continuous Ops | 0.19 | 0.21 | 0.15 | 0.14 | 0.11 |
| EPS Diluted Total Ops | 0.19 | 0.20 | 0.15 | 0.14 | 0.11 |
| EPS Diluted Continuous Ops | 0.19 | 0.20 | 0.15 | 0.14 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.19 | 0.20 | 0.16 | 0.15 | 0.14 |
| EBITDA(a) | $60,268 | $64,959 | $53,169 | $44,981 | $37,004 |